Prospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jan 21, 2017; 23(3): 540-546
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.540
Table 1 Patients’ characteristics
Characteristicn (%)
Age (yr)
Median58 (37-74)
Gender
Male63 (82.9)
Female13 (17.1)
Stage1
II21 (27.6)
III27 (35.5)
IV28 (30.3)
Fraction regimen
LCAF16 (21.1)
CF60 (78.9)
Number of chemotherapy cycles
18 (10.5)
213 (17.1)
37 (9.2)
448 (63.2)
Status
Survival17 (22.4)
Dead53 (69.7)
Lost to follow-up6 (7.9)